ClinicalTrials.Veeva

Menu

Virtual Reality in End Stage Kidney Disease

University of Pennsylvania logo

University of Pennsylvania

Status

Not yet enrolling

Conditions

End Stage Kidney Disease

Treatments

Behavioral: Social Virtual Reality
Behavioral: Individual Virtual Reality

Study type

Interventional

Funder types

Other

Identifiers

NCT06356168
SVR/IVR

Details and patient eligibility

About

The goal of this clinical trial to compare the social virtual reality and individual virtual reality in patients with end stage kidney disease who are hemodialysis. The main aim is to determine if there are differences in symptoms between the groups. Participants will use virtual reality glasses for 30-45 minutes during dialysis sessions for 4 weeks.

Full description

In a single site, 2-arm (Social Virtual Reality group; Individual Virtual Reality Group), parallel, randomized controlled trial we will enroll 60 subjects (n=30 per group) to assess the effects of Social Virtual Reality to Individual Virtual Reality on symptoms in participants with end stage kidney disease who are receiving hemodialysis.

To compare the effects of social virtual reality to individual virtual reality on loneliness To explore the effects of social virtual reality to individual virtual reality on anxiety and depression.

To compare the effects social virtual reality to individual virtual reality on quality of life.

Enrollment

60 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria

  • Diagnosis of end stage kidney disease with hemodialysis 3 times per week for at least 1 month

Exclusion Criteria

  • Acutely ill
  • Active nausea
  • Epilepsy

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

60 participants in 2 patient groups

Social Virtual Reality
Experimental group
Description:
Social Virtual Reality will be delivered using virtual reality glasses for 30-45 minutes during dialysis sessions. Groups of 3 participants will watch a movie or program together through the glasses. They will be able to talk and interact during the session.
Treatment:
Behavioral: Social Virtual Reality
Individual Virtual Reality
Active Comparator group
Description:
Individual Virtual Reality will be delivered using virtual reality glasses for 30-45 minutes during dialysis sessions. Those randomized to this arm will watch a movie or program alone through the glasses.
Treatment:
Behavioral: Individual Virtual Reality

Trial contacts and locations

0

Loading...

Central trial contact

Lea Ann Matura, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems